News
President Trump said Britain had agreed to increase market access for billions of dollars in American exports, including beef ...
In an interview with the conservative talk show host Hugh Hewitt, President Trump expanded his threat to revoke the ...
Enter SuperThin, a cutting-edge dietary supplement that leverages the power of grapefruit extract and other bile-thinning ...
The Daily Mirror runs with an exclusive on the alleged row between David and Victoria Beckham and their son Brooklyn and his ...
Rentokil has also replaced two current non-executive directors with Leanne Sheraton, former chief marketing officer at Paypal ...
Medicare recipients suffering from obesity must pay out of pocket for weight loss drugs like Wecovy and Zepbound.
State Medicaid programs have the choice of whether or not to cover GLP-1 drugs for the treatment of obesity ... is FDA approved for chronic weight management. In December, it became the first ...
Physicians describe common prior authorization challenges when treating patients for obesity and share strategies to overcome ...
Obesity is one of the most visible public health challenges of our time, yet it remains one of the most misunderstood. For millions of older Americans, it's a daily struggle ...
The House Ways and Means Committee in the US voted in favour of a new bill which would end a two-decade-long restriction on the coverage of drugs to treat obesity ... which helps cover the cost ...
Ooops... Something went wrong while loading this page.
The current approach to diagnosing obesity based on body mass index (BMI) is not fit for purpose as a marker for health – and by extension decisions on prescribing weight-loss therapies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results